Literature DB >> 16882099

Efficacy and safety of over-the-counter analgesics in the treatment of common cold and flu.

R Eccles1.   

Abstract

RATIONALE: Common cold and flu are the most common human illnesses, and over-the-counter (OTC) analgesics are widely used to treat the pain and fever symptoms. Despite the every day use of these analgesic there is little information available in the literature on the efficacy and safety of these medicines in treating colds and flu symptoms. The aim of this review was to determine the safety and efficacy of the analgesics, aspirin, paracetamol and aspirin for the treatment of colds and flu.
METHODS: Electronic databases and a personal database were searched and the information retrieved together with information from relevant textbooks has been integrated in the review.
RESULTS: The literature search established that there is relatively little information on the use of analgesics in treating colds and flu and that much of the safety and efficacy data must be related to other pain and fever models. The review establishes that aspirin, paracetamol and ibuprofen are safe in OTC doses and that there is no evidence for any difference between the medicines as regards efficacy and safety for treatment of colds and flu (except in certain cases such as the use of aspirin in feverish children). There is also no evidence that these medicines prolong the course of colds and flu by any effect on the immune system or by reducing fever.
CONCLUSION: Despite the lack of clinical data on the safety and efficacy of analgesics for the treatment of colds and flu symptoms a case can be made that these medicines are safe and effective for treatment of these common illnesses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882099     DOI: 10.1111/j.1365-2710.2006.00754.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  18 in total

1.  Management of upper respiratory tract infections in children.

Authors:  Mf Cotton; S Innes; H Jaspan; A Madide; H Rabie
Journal:  S Afr Fam Pract (2004)       Date:  2008-03

2.  Efficacy of phenyl quinoline phenol derivatives as COX-2 inhibitors; an approach to emergent the small molecules as the anti-inflammatory and analgesic therapeutics.

Authors:  A Manikandan; S Ravichandran; K I Sathiyanarayanan; A Sivakumar
Journal:  Inflammopharmacology       Date:  2017-04-04       Impact factor: 4.473

Review 3.  Teaching an old dog new tricks: Drug discovery by repositioning natural products and their derivatives.

Authors:  Boshi Huang; Yan Zhang
Journal:  Drug Discov Today       Date:  2022-02-16       Impact factor: 8.369

Review 4.  Efficacy and Safety of Ibuprofen in Infants Aged Between 3 and 6 Months.

Authors:  Victoria C Ziesenitz; Andreas Zutter; Thomas O Erb; Johannes N van den Anker
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

5.  Effects of upper respiratory tract illnesses, ibuprofen and caffeine on reaction time and alertness.

Authors:  Andrew P Smith; David J Nutt
Journal:  Psychopharmacology (Berl)       Date:  2013-11-28       Impact factor: 4.530

Review 6.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

Review 7.  Oral antihistamine-decongestant-analgesic combinations for the common cold.

Authors:  An Im De Sutter; Lars Eriksson; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2022-01-21

8.  A new sensitive sensor for simultaneous differential pulse voltammetric determination of codeine and acetaminophen using a hydroquinone derivative and multiwall carbon nanotubes carbon paste electrode.

Authors:  Elahe Garazhian; M Reza Shishehbore
Journal:  Int J Anal Chem       Date:  2015-04-06       Impact factor: 1.885

9.  Analgesic and Decongestant Efficacy of the Combination of Aspirin with Pseudoephedrine in Patients With Symptoms of Upper Respiratory Tract Infection.

Authors:  Ronald Eccles; Michael Voelker
Journal:  Clin Pharmacol Drug Dev       Date:  2013-08-20

10.  Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold.

Authors:  Tamas Fazekas; Philipp Eickhoff; Nathalie Pruckner; Georg Vollnhofer; Gustav Fischmeister; Christopher Diakos; Margit Rauch; Maria Verdianz; Andreas Zoubek; Helmut Gadner; Thomas Lion
Journal:  BMC Complement Altern Med       Date:  2012-09-05       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.